It can directly combine with toxic substances to make them excreted from the body, or it can indirectly remove toxic substances by increasing the activity of two enzymes, GSH-Px and GST, and finally weaken or eliminate the influence of toxic substances on the body
Clinical Pharmacology of GLP-1 RAs The approval of the first GLP-1 RA, exenatide, by the FDA in 2005 marked a significant advancement in treating diabetes and obesity
Jojima T, Uchida K, Akimoto K, Tomotsune T, Yanagi K, Iijima T, Suzuki K, Kasai K, Aso Y
Microglial TLR4-induced TAK1 phosphorylation and NLRP3 activation mediates neuroinflammation and contributes to chronic morphine-induced antinociceptive tolerance
This product provides 2 g of a single amino acid